Targeting the tumor microenvironment with chemically modified tetracyclines: Inhibition of laminin 5 γ2 chain promigratory fragments and vasculogenic mimicry

Molecular Cancer Therapeutics

Volumn 1, Issue 13, 2002, Pages 1173-1179

  Seftor, Richard E B ^a   Seftor, Elisabeth A ^a   Kirschmann, Dawn A ^a   Hendrix, Mary J C ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; ENDOTHELIAL CELL GROWTH FACTOR; GELATINASE A; KALININ; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PRIMER DNA; PROTEIN TYROSINE KINASE; TETRACYCLINE; TETRACYCLINE CMT 3; TETRACYCLINE CMT-3; TETRACYCLINE DERIVATIVE; TIE RECEPTOR; VASCULOTROPIN C;

ARTICLE; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MELANOMA; METABOLISM; MOLECULAR MIMICRY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHASE CONTRAST MICROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN TUMOR; UVEA TUMOR; VASCULARIZATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION MOLECULES; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; METALLOENDOPEPTIDASES; MICROSCOPY, PHASE-CONTRAST; MOLECULAR MIMICRY; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; RECEPTORS, TIE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TETRACYCLINE; TETRACYCLINES; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 0013268010     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Seftor, R. E. B., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M. G., Bilban, M., Stetler-Stevenson, W. G., Quaranta, V., and Hendrix, M. J. C. Cooperative interactions of laminin 5 γ2 chain, matrix metallo-proteinase-2, membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res., 61: 6322-6327, 2001. (Pubitemid 32783230)
2. Seftor, R. E. B., Seftor, E. A., De Larco, J. E., Kleiner, D. E., Leferson, J., Stetler-Stevenson, W. G., McNamara, T. F., Golub, L. M., and Hendrix, M. J. C. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis. Clin. Exp. Metastasis, 16: 215-225, 1998.
3. Lee, H. M., Golub, L. M., Cao, J., Teronen, O., Laitinen, M., Salo, T., Zucker, S., and Sorsa, T. CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer. Curr. Med. Chem., 8: 257-260, 2001. (Pubitemid 32409777)
4. Lokeshwar, B. L., Selzer, M. G., Zhu, B. Q., Block, N. L., and Golub, L. M. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int. J. Cancer, 98: 297-309, 2002. (Pubitemid 34150817)
5. Duivenvoorden, W. C., Popovic, S. V., Lhotak, S., Seidlitz, E., Hirte, G. W., Tozer, R. G., and Singh, G. Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer. Cancer Res., 62: 1588-1591, 2002. (Pubitemid 34408474)
6. Lamparter, S., Slight, S. H., and Weber, K. T. Doxycycline and tissue repair in rats. J. Lab. Clin. Med., 139: 295-302, 2002. (Pubitemid 34577481)
7. Sipos, E. P., and Brem, H. Local anti-angiogenic brain tumor therapies. J. Neurooncol., 50: 181-188, 2000. (Pubitemid 32166300)
8. Rudek, M. A., Horne, M., Figg, W. D., Dahut, W., Dyer, V., Pluda, J. M., and Reed, E. Reversible sideroblastic anemia associated with tetracycline analogue COL-3. Am. J. Hematol., 67: 51-53, 2001. (Pubitemid 32336705)
9. Rudek, M. A., Figg, W. D., Dyer, V., Dahut, W., Turner, M. L., Steinberg, S. M., Liewehr, D. J., Kohler, D. R., Pluda, J. M., and Reed, E. Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer. J. Clin. Oncol., 19: 584-592, 2001. (Pubitemid 32112874)
10. Ghate, J. V., Turner, M. L., Rudek, M. A., Figg, W. D., Dahut, W., Dyer, V., Pluda, J. M., and Reed, E. Drug-induced lupus associated with COL-3. Arch. Dermatol., 37: 471-474, 2001.
11. Welch, D. R., Bisi, J. E., Miller, B. E., Conaway, D., Seftor, E. A., Yohem, K. H., Gilmore, L. B., Seftor, R. E. B., Nakajima, M., and Hendrix, M. J. C. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer, 47: 227-237, 1991.
12. Hendrix, M. J. C., Seftor, E. A., Meltzer, P. S., Gardner, L. M. G., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., and Seftor, R. E. B. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl. Acad. Sci. USA, 98: 8018-8023, 2001. (Pubitemid 32642679)
13. Hendrix, M. J. C., Seftor, R. E. B., Seftor, E. A., Gruman, L. M., Lee, L. M., Nickoloff, J., Miele, L., Sheriff, D. D., and Schatteman, G. C. Transendothelial function of human metastatic melanoma cells: role of the microenvironment in cell-fate determination. Cancer Res., 62: 665-668, 2002. (Pubitemid 34126938)
14. Seftor, E. A., Meltzer, P. S., Kirschmann, D. A., Pe'er, J., Maniotis, A. J., Trent, J. M., Folberg, R., and Hendrix, M. J. C. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis, 19: 233-246, 2002. (Pubitemid 34553524)
15. Seftor, E. A., Meltzer, P. S., Schatteman, G. C., Gruman, L. M., Hess, A. R., Kirschmann, D. A., Seftor, R. E. B., and Hendrix, M. J. C. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit. Rev. Oncol. Hematol., 44: 17-27, 2002. (Pubitemid 35175468)
16. Seftor, R. E. B. Electrophoretic analysis of proteins associated with tumor cell invasion. Electrophoresis, 15: 454-468, 1994.
17. Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe'er, J., Trent, J. M., Meltzer, P. S., and Hendrix, M. J. C. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol., 155: 739-752, 1999. (Pubitemid 29426820)
18. Folberg, R., Hendrix, M. J. C., and Maniotis, A. J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol., 156: 361-381, 2000. (Pubitemid 30648785)
19. Golub, L. M., Ramamurthy, N. S., McNamara, T. F., Greenwald, R. A., and Rifkin, B. R. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit. Rev. Oral. Biol. Med., 2: 297-321, 1991.
20. Ryan, M. E., Greenwald, R. A. and Golub, L. M. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr. Opin. Rheumatol., 8: 238-247, 1996. (Pubitemid 26192788)
21. Pirila, E., Parikka, M., Ramamurthy, N. S., Maisi, P., McClaine, S., Kucine, A., Tervahartiala, T., Prikk, K., Golub, L. M., Salo, T., and Sorsa, T. Chemically modified tetracycline (CMT-8) and estrogen promote wound healing in ovariectomized rats: effects on matrix metalloproteinase-2, membrane type 1 matrix metalloproteinase, and laminin-5 γ2-chain. Wound Repair Regen., 10: 38-51, 2002. (Pubitemid 34496480)
22. Nip, L. H., Uitto, V-J., and Golub, L. M. Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J. Periodont. Res., 28: 379-385, 1993. (Pubitemid 23282035)
23. Alarcon, G. S. Tetracyclines for the treatment of rheumatoid arthritis. Expert Opin. Investig. Drugs, 9: 1491-1498, 2000. (Pubitemid 30433709)
24. Baxter, B. T., Pearce, W. H., Waltke, E. A., Littooy, F. N., Hallett, J. W., Jr., Kent, K. C., Upchurch, G. R., Jr., Chaikof, E. L., Mills, J. L., Fleckten, B., Longo, G. M., Lee, J. K., and Thompson, R. W. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J. Vasc. Surg., 36: 1-12, 2002. (Pubitemid 41122881) Health